Evidence map›Paper›PMID 36274067›Full record

ArticleLeukemia2022

Clonal hematopoiesis is associated with hematological toxicity during lenalidomide-based therapy for MCL.

Simon Husby, Cecilie Bæch-Laursen, Christian W Eskelund, Francesco Favero, Jakob Schmidt Jespersen, Martin Hutchings, Lone Bredo Pedersen, Carsten U Niemann, Joachim Weischenfeldt, Riikka Räty and 4 more

Abstract read
PubMed Publisher
In one paragraph

Article in Leukemia, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Clonal hematopoiesis withHaematologica · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Simon HusbyDepartment of Hematology, Rigshospitalet, Copenhagen, Denmark. simon.husby.01@regionh.dk.ORCID http://orcid.org/0000-0002-6332-1173
Cecilie Bæch-LaursenDepartment of Hematology, Rigshospitalet, Copenhagen, Denmark.ORCID http://orcid.org/0000-0002-8526-1079
Christian W EskelundDepartment of Hematology, Rigshospitalet, Copenhagen, Denmark.
Francesco FaveroBiotech Research and Innovation Center (BRIC), University of Copenhagen, Copenhagen, Denmark.ORCID http://orcid.org/0000-0003-3684-2659
Jakob Schmidt JespersenBiotech Research and Innovation Center (BRIC), University of Copenhagen, Copenhagen, Denmark.ORCID http://orcid.org/0000-0002-4930-5900
Martin HutchingsDepartment of Hematology, Rigshospitalet, Copenhagen, Denmark.
Lone Bredo PedersenDepartment of Hematology, Rigshospitalet, Copenhagen, Denmark.
Carsten U NiemannDepartment of Hematology, Rigshospitalet, Copenhagen, Denmark.ORCID http://orcid.org/0000-0001-9880-5242
Joachim WeischenfeldtBiotech Research and Innovation Center (BRIC), University of Copenhagen, Copenhagen, Denmark.ORCID http://orcid.org/0000-0002-3917-5524
Riikka RätyDepartment of Hematology, Helsinki University Central Hospital, Helsinki, Finland.
Thomas Stauffer LarsenDepartment of Hematology, Odense University Hospital, Odense, Denmark.ORCID http://orcid.org/0000-0002-8418-6708
Arne KolstadDepartment of Oncology, Innlandet Hospital, Lillehammer, Norway.
Mats JerkemanDepartment of Oncology, Lund University Hospital, Lund, Sweden.ORCID http://orcid.org/0000-0003-4509-6707
Kirsten GrønbækDepartment of Hematology, Rigshospitalet, Copenhagen, Denmark.ORCID http://orcid.org/0000-0002-1535-9601

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Clonal HematopoiesisLymphoma, Mantle-CellHematopoiesisHumansLenalidomideNeoplasm Recurrence, LocalThalidomideLenalidomideThalidomide

Identifiers

PMID36274067

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.